Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Helium One reports encouraging flow testing at Jackson-29

(Sharecast News) - Helium One Global reported encouraging flow test results from the Jackson-29 well at the Galactica Project in Colorado on Tuesday, where it holds a 50% working interest in a joint venture with Blue Star Helium. The AIM-traded firm said the well, drilled to a total depth of 1,183 feet within the Lyons Sandstone Formation, encountered high-quality, gas-saturated reservoir rock without the presence of water, as expected.

It said the Jackson-29 well had been flowing naturally since reaching total depth, with current flow rates exceeding 320,000 cubic feet per day.

Stabilised flow rates were projected at between 350,000 and 450,000 cubic feet daily, with a maximum potential of 550,000, based on engineering studies and observed reservoir performance.

Pressure build-up data indicated strong permeability and reservoir communication.

Preliminary gas analysis returned a helium concentration of up to 3.30% air-corrected, alongside 48.66% carbon dioxide and 48.04% nitrogen, consistent with geological expectations.

The Galactica Project, which forms part of the larger Galactica-Pegasus development discovered in 2022, offered multiple potential product streams and is located adjacent to the third-party Red Rocks helium project, the board said.

Helium One is funding the initial $0.45m of drilling under its farm-in agreement, and said the results supported the commercial viability of the Galactica Project as it continued to progress development plans with Blue Star.

At 0939 BST, shares in Helium One Global were down 1.46% at 0.91p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

BioNTech to invest up to £1bn in UK R&D expansion
(Sharecast News) - BioNTech announced on Tuesday that it will invest up to £1bn over the next decade to expand its research and development footprint in the UK, backed by a government grant of up to £129m.
Image Scan warns on profits, shares slump
(Sharecast News) - Shares in Image Scan tumbled on Tuesday, after the X-ray screening specialist warned on profits following a "disappointing" first half.
Mosman Oil & Gas in talks to sell Billy Goat rights
(Sharecast News) - Mosman Oil and Gas said on Tuesday that it has been in talks with a local helium business interested in buying the first well and associated contractual rights of the Billy Goat area of mutual interest (AMI) lease at its Vecta Project in Colorado.
RBC Capital ups price target on Hikma
(Sharecast News) - RBC Capital Markets has upped both forecasts and its price target for blue chip generics specialist Hikma Pharmaceuticals.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.